Literature DB >> 22672977

Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine.

.   

Abstract

During the 2011-12 influenza season in the United States, influenza activity* occurred at low levels during October through December and increased in January and February before peaking in mid-March. Influenza A (H3N2) viruses predominated overall, but influenza A (H1N1)pdm09 (pH1N1) and influenza B viruses also circulated widely. This influenza season was mild compared with recent years, with a lower percentage of outpatient visits for influenza-like illness (ILI),† lower rates of hospitalizations, and fewer deaths attributed to pneumonia and influenza. This report summarizes influenza activity in the United States during the 2011-12 influenza season (October 2, 2011-May 19, 2012) and reports the recommendations for the components of the 2012-13 Northern Hemisphere influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22672977

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  43 in total

1.  Evaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza season.

Authors:  William Murtaugh; Lalla Mahaman; Benjamin Healey; Heather Peters; Barbara Anderson; Mandy Tran; Marci Ziese; Maria Paz Carlos
Journal:  Public Health Rep       Date:  2013 Sep-Oct       Impact factor: 2.792

2.  Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.

Authors:  Michael L Jackson; Lisa A Jackson; Burney Kieke; David McClure; Manjusha Gaglani; Kempapura Murthy; Ryan Malosh; Arnold Monto; Richard K Zimmerman; Ivo M Foppa; Brendan Flannery; Mark G Thompson
Journal:  Vaccine       Date:  2015-08-11       Impact factor: 3.641

3.  Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.

Authors:  Nimalan Arinaminpathy; Inkyu Kevin Kim; Paul Gargiullo; Michael Haber; Ivo M Foppa; Manoj Gambhir; Joseph Bresee
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

4.  The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia.

Authors:  April Sykes; Elsie Gerhardt; Li Tang; Elisabeth E Adderson
Journal:  J Pediatr       Date:  2017-12       Impact factor: 4.406

5.  A randomized trial of maternal influenza immunization decision-making: A test of persuasive messaging models.

Authors:  Paula M Frew; Jennifer L Kriss; Allison T Chamberlain; Fauzia Malik; Yunmi Chung; Marielysse Cortés; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

6.  Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease.

Authors:  J Bradley Layton; Leah J McGrath; John M Sahrmann; Yinjiao Ma; Vikas R Dharnidharka; Caroline O'Neil; David J Weber; Anne M Butler
Journal:  Vaccine       Date:  2020-06-19       Impact factor: 3.641

7.  Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness.

Authors:  Shuo Feng; Ashley L Fowlkes; Andrea Steffens; Lyn Finelli; Benjamin J Cowling
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

8.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

9.  Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.

Authors:  Benjamin J Cowling; Shuo Feng; Lyn Finelli; Andrea Steffens; Ashley Fowlkes
Journal:  Vaccine       Date:  2015-11-21       Impact factor: 3.641

10.  Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.

Authors:  Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.